Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.
Impact
By instituting this bill, New Jersey aims to address the public health concerns associated with products containing 7-OH, which the FDA has identified as having a high potential for abuse and no accepted medical uses in treatment. The bill outlines a structured recall process whereby manufacturers, distributors, and retailers must act promptly to remove potentially harmful products from the market. Violations of the bill could lead to criminal charges, with penalties ranging from fines to imprisonment depending on the severity and frequency of the offenses. This legislative action is likely to have significant implications for the sale and distribution of herbal supplements and could set a precedent for how similar substances are regulated in the future.
Summary
Assembly Bill A1636 proposes the classification of 7 Hydroxymitragynine (7-OH) as a Schedule I controlled dangerous substance in the state of New Jersey. This classification will effectively ban the sale, distribution, or manufacture of products containing 7-OH, a psychoactive alkaloid derived from the Mitragyna speciosa plant, commonly known as Kratom. The bill aims to protect consumers from potentially dangerous products that could lead to addiction, as 7-OH has been associated with opioid-like effects, posing serious health risks. This process is driven by the rising trend of consumers purchasing high concentrations of 7-OH products without clear and safe dosing instructions provided on labels.
Contention
As with many regulatory measures, A1636 presents points of contention. Supporters of the bill, including health advocates, argue that it is necessary for protecting public health by limiting access to substances that can lead to addiction. Opponents may argue that this creates unnecessary restrictions on natural products and could hinder personal choice within the marketplace. Some may also contend that this legislative approach might drive the product underground, leading to unregulated use, which could pose additional risks to consumers.